Dendritic cells transduced with autoantigen FCRLA induce cytotoxic lymphocytes and vaccinate against murine B-cell lymphoma

Journal of Investigative Dermatology

Volumn 127, Issue 12, 2007, Pages 2818-2822

  Inozume, Takashi ^a   Mitsui, Hiroshi ^a   Okamoto, Takashi ^a   Matsuzaki, Yuriko ^b   Kawakami, Yutaka ^b   Shibagaki, Naotaka ^a   Shimada, Shinji ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; FC RECEPTOR LIKE A; HYBRID PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; B CELL LYMPHOMA; CANCER CELL CULTURE; CYTOTOXIC LYMPHOCYTE; DENDRITIC CELL; FEMALE; IMMUNOGENICITY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; VACCINATION;

EID: 36248996415     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700909     Document Type: Article

References (9)

1. Davis RS, Li H, Chen C, Wang Y, Cooper MD, Burrows PD (2002) Definition of an Fc receptor-related gene (FcRX) expressed in human and mouse B cells. Int Immunol 14:1075-83
2. Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ et al. (2002) Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298:850-4
3. Facchetti F, Cella M, Festa S, Fremont DH, Colonna M (2002) An unusual Fc receptor-related protein expressed in human centroblasts. Proc Natl Acad Sci USA 99:3776-81
4. Inozume T, Matsuzaki Y, Kurihara S, Fujita T, Yamamoto A, Aburatani H et al. (2005) Novel melanoma antigen, FCRL/FREB, identified by cDNA profile comparison using DNA chip are immunogenic in multiple melanoma patients. Int J Cancer 114:283-90
5. Maltais LJ, Lovering RC, Taranin AV, Colonna M, Ravetch JV, Dalla-Favera R et al. (2006) New nomenclature for Fc receptor-like molecules. Nat Immunol 7:431-2
6. Masir N, Jones M, Pozzobon M, Marafioti T, Volkova OY, Mechetina LV et al. (2004) Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells. Br J Haematol 127:335-43
7. Mechetina LV, Najakshin AM, Volkova OY, Guselnikov SV, Faizulin RZ, Alabyev BY et al. (2002) FCRL, a novel member of the leukocyte Fc receptor family possesses unique structural features. Eur J Immunol 32:87-96
8. Mitsui H, Inozume T, Kitamura R, Shibagaki N, Shimada S (2006) Polyarginine-mediated protein delivery to dendritic cells presents antigen more efficiently onto MHC class I and celass II and elicits superior antitumor immunity. J Invest Dermatol 126:1804-12
9. Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL et al. (1998) Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 4:321-7